Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines to Meet Legal Demands.
Deadline: 27 Apr 2026
Posting Date: 13 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139458130
Document Ref. No.: 90229/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Acquisition of Medicines to meet Legal Demands. UASG code: 90201 Notice from: 04/13/2026 from 08:00 to 12:00 and from 13:00 to 17:59 Proposal Delivery: from 04/13/2026 at 08:00 DEFLAZACORTE, CONCENTRATION 30 MG Quantity: 960 PROPRANOLOL HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH HYDROCHLOROTHIAZIDE, CONCENTRATION40 MG + 25 MG Quantity: 180 TELMISARTAN, ACTIVE INGREDIENT ASSOCIATED WITH HYDROCHLOROTHIAZIDE, DOSAGE 40MG + 12.5MG Quantity: 180 ALUMINUM HYDROXIDE, COMPOSITION ASSOC. TO MAGNESIUM HYDROXIDE AND CALCIUM CARBONATE, CONCENTRATION 178 MG + 185 MG + 230 MG, PHARMACEUTICAL FORM CHEWABLE TABLET Quantity: 600 MAGNESIUM HYDROXIDE, COMPOSITION ASSOCIATED WITH ALUMINUM HYDROXIDE AND SIMETICONE, CONCENTRATION 40 MG + 37 MG + 5 MG/ML, PHARMACEUTICAL FORM, ORAL SUSPENSION Quantity: 21600 ALUMINUM HYDROXIDE, COMPOSITION ASSOCIATED WITH MAGNESIUM HYDROXIDE AND DIMETHICONE, CONCENTRATION 37 MG + 40 MG + 5 MG/ML, FORM PHARMACEUTICAL ORAL SUSPENSION Quantity: 5400 LANSOPRAZOLE, COMPOSITION ASSOCIATED WITH AMOXICILLIN AND CLARITHROMYCIN, DOSAGE 30MG+ 500MG + 500MG Quantity: 14 METHYLPREDNISOLONE, ACTIVE INGREDIENT ACETATE SALT, DOSAGE 40 MG/ML, PHARMACEUTICAL FORM SUSPENSION INJECTABLE Quantity: 2 NAFAZOLINE, ACTIVE INGREDIENT ASSOCIATED WITH ZINC SULFATE, DOSAGE 0.15MG + 0.3MG/ML, PRESENTATION OF OPHTHALMIC SOLUTION Quantity: 129 NAPROXEN, COMPOSITION ASSOCIATED WITH SUMATRIPTAN, CONCENTRATION 500 MG + 50 MG Quantity: 360 NIFEDIPINE, CONCENTRATION 40 MG, ADDITIONAL CHARACTERISTICS 1 PROLONGED RELEASE Quantity: 360 OXIMETAZOLINE HYCLORHYDRATE, DOSAGE 0.50 MG/ML, ADULT NASAL SOLUTION PRESENTATION, USE DROPS Quantity: 180 PREDNISOLONE, ACETATE COMPOSITION, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC SUSPENSION Quantity: 60 SIMETICONE, CONCENTRATION 40 MG Quantity: 120
Documents
Tender Notice